Evidence map›Paper›PMID 9761728›Full record

ArticleThe Biochemical journal1998

Characterization of the hypertonically induced tyrosine phosphorylation of erythrocyte band 3.

G Minetti, C Seppi, A Ciana, C Balduini, P S Low, A Brovelli

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

G MinettiDipartimento di Biochimica 'A. Castellani', Università di Pavia, Via Bassi 21, I-27100 Pavia, Italy.
C Seppi
A Ciana
C Balduini
P S Low
A Brovelli
University of Pavia · ITPurdue University West Lafayette · US

Funding

Studies of Erythrocyte Membrane StructureR01GM024417 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI LOW, PHILIP STEWART · 1985 to 2020
$5.4M
ERYTHROCYTE MEMBRANE STRUCTURER37GM024417 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI LOW, PHILIP STEWART · 1999 to 2008
$3.5M
NIGMS NIH HHS GM24417
6 · The paper itself

Abstract

Human erythrocyte band 3 becomes rapidly phosphorylated on tyrosine residues after exposure of erythrocytes to hypertonic conditions. The driving force for this phosphorylation reaction seems to be a decrease in cell volume, because (1) changes in band 3 phosphotyrosine content accurately track repeated changes in erythrocyte volume through several cycles of swelling and shrinking; (2) the level of band 3 phosphorylation is independent of the osmolyte employed but strongly sensitive to the magnitude of cell shrinkage; and (3) exposure of erythrocytes to hypertonic buffers under conditions in which intracellular osmolarity increases but volume does not change (nystatin-treated cells) does not promote an increase in tyrosine phosphorylation. We hypothesize that shrinkage-induced tyrosine phosphorylation results either from an excluded-volume effect, stemming from an increase in intracellular crowding, or from changes in membrane curvature that accompany the decrease in cell volume. Although the net phosphorylation state of band 3 is shown to be due to a delicate balance between a constitutively active tyrosine phosphatase and constitutively active tyrosine kinase, the increase in phosphorylation during cell shrinkage was demonstrated to derive specifically from an activation of the latter. Further, a peculiar inhibition pattern of the volume-sensitive erythrocyte tyrosine kinase that matched that of p72syk, a tyrosine kinase already known to associate with band 3 in vivo, suggested the involvement of this kinase in the volume-dependent response.

Indexed as

AnimalsAnion Exchange Protein 1, ErythrocyteCell SizeCytosolEnzyme InhibitorsEnzyme PrecursorsErythrocytesHumansHypertonic SolutionsIntracellular Signaling Peptides and ProteinsOsmolar ConcentrationPhosphoric Monoester HydrolasesPhosphorylationProtein-Tyrosine KinasesRecombinant ProteinsStaurosporineAnion Exchange Protein 1, ErythrocyteEnzyme InhibitorsEnzyme PrecursorsHypertonic SolutionsIntracellular Signaling Peptides and ProteinsPhosphoric Monoester HydrolasesProtein-Tyrosine KinasesRecombinant ProteinsStaurosporineSyk KinaseSYK protein, humanTyrosine

Identifiers

PMID9761728
PMCPMC1219783
OpenAlexW1874922015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.